UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.021

Sortiert nach

A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasis

British journal of dermatology (1951), 2016-06, Vol.174 (6), p.1266-1276

2016

Volltextzugriff (PDF)

THU0149 Efficacy and Safety of Baricitinib in Japanese Rheumatoid Arthritis Patients at 12 Weeks

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.231

2014

Volltextzugriff (PDF)

Wpływ typu gleby, pH, wilgotności i temperatury na fitotoksyczność i skuteczność zwalczania głowni cebuli (Urocystis magica Pass.) fungicydami z grup PCNB i TMTD

Acta agrobotanica, 2015-06, Vol.27 (1), p.85

2015

Volltextzugriff (PDF)

THU0175 Effects of Baricitinib on Multibiomarker Disease Activity Scores and Their Components in a Phase 2B Study in Moderate-to-Severe Rheumatoid Arthritis Patients

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.257

2015

Volltextzugriff (PDF)

OP0047 Baricitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-Label, Long-Term Extension Study

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A65-A66

2013

Volltextzugriff (PDF)

OP0029 Baricitinib, An Oral Janus Kinase (JAK)1/JAK2 Inhibitor, in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to TNF Inhibitors: Results of the Phase 3 RA-Beacon Study

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.75-76

2015

Volltextzugriff (PDF)

THU0226 Baricitinib Effects on Serum Cholesterol and Circulating Lipid Particles in a Phase 2B Study in Patients with Rheumatoid Arthritis

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A241-A241

2013

Volltextzugriff (PDF)

Cytochrome P-450 Polymorphisms and Response to Clopidogrel

The New England journal of medicine, 2009-01, Vol.360 (4), p.354-362

2009

Volltextzugriff (PDF)

Extracorporeal therapy requirements for patients with acute renal failure

Journal of the American Society of Nephrology, 1997-05, Vol.8 (5), p.804-812

1997

Volltextzugriff (PDF)

A comparison of metabolic control by continuous and intermittent therapies in acute renal failure

Journal of the American Society of Nephrology, 1994-01, Vol.4 (7), p.1413-1420

1994

Volltextzugriff (PDF)

Drotrecogin Alfa (Activated) in Adults with Septic Shock

The New England journal of medicine, 2012-05, Vol.366 (22), p.2055-2064

2012

Volltextzugriff (PDF)

Plasma protein adsorption to highly permeable hemodialysis membranes

Kidney international, 1995-08, Vol.48 (2), p.481-488

1995

Volltextzugriff (PDF)

Activated protein C levels in patients with severe sepsis: rebuttal

Journal of thrombosis and haemostasis, 2004-02, Vol.2 (2), p.366-366

2004

Volltextzugriff (PDF)

THU0149 Efficacy and Safety of Baricitinib in Japanese Rheumatoid Arthritis Patients at 12 Weeks: Table 1

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.231-231

2014

Volltextzugriff (PDF)

Impact of the Nutritional Regimen on Protein Catabolism and Nitrogen Balance in Patients With Acute Renal Failure

JPEN. Journal of parenteral and enteral nutrition, 1996-01, Vol.20 (1), p.56-62

1996

Volltextzugriff (PDF)

Quantification of creatinine kinetic parameters in patients with acute renal failure

Kidney international, 1998-08, Vol.54 (2), p.554-560

1998

Volltextzugriff (PDF)

A blind clinical evaluation committee should, in theory, make data of a randomized clinical trial stronger, not weaker

Intensive care medicine, 2004-05, Vol.30 (5), p.995-995

2004

Volltextzugriff (PDF)

Identification, Management, and Transition of Care for Patients With Opioid Use Disorder in the Emergency Department

Annals of emergency medicine, 2018-10, Vol.72 (4), p.420-431

2018

Volltextzugriff (PDF)

Antithrombin and heparin may limit the activation of Protein C

Acta anaesthesiologica Scandinavica, 2004-03, Vol.48 (3), p.385-385

2004

Volltextzugriff (PDF)

Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death

The New England journal of medicine, 2005-09, Vol.353 (13), p.1332-1341

2005

Volltextzugriff (PDF)

The Return of the House Call: The Role of Internet-Based Interactivity in Bringing Health Information Home to Older Adults

Health communication, 2008-01, Vol.23 (1), p.34-44

2008

Volltextzugriff (PDF)

Vancomycin pharmacokinetics in acute renal failure: Preservation of nonrenal clearance

Clinical pharmacology and therapeutics, 1991-12, Vol.50 (6), p.688-694

1991

Volltextzugriff (PDF)

A CONTENT ANALYSIS OF DIRECT-TO-CONSUMER (DTC) PRESCRIPTION DRUG WEB SITES

Journal of advertising, 2003-12, Vol.32 (4), p.43-56

2003

Volltextzugriff (PDF)

THU0175 Effects of Baricitinib on Multibiomarker Disease Activity Scores and Their Components in a Phase 2B Study in Moderate-to-Severe Rheumatoid Arthritis Patients: Table 1

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.257-258

2015

Volltextzugriff (PDF)

Comparison of imipenem pharmacokinetics in patients with acute or chronic renal failure treated with continuous hemofiltration

American journal of kidney diseases, 1993-02, Vol.21 (2), p.172-179

1993

Volltextzugriff (PDF)

1 – 25 von 1.021

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(927)
Mit Volltextzugriff
(915)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(709)
Life Sciences & Biomedicine
(387)
Physical Sciences
(294)
Humans
(235)
Physics
(194)
Astronomy & Astrophysics
(179)
Astrophysics
(168)
Male
(121)
Female
(118)
Biological And Medical Sciences
(98)
Sciences Of The Universe
(91)
Animals
(89)
Astronomy And Astrophysics
(88)
Cosmology And Extra-Galactic Astrophysics
(85)
Cosmology: Observations
(82)
Cosmic Background Radiation
(81)
Technology
(75)
Medical Sciences
(72)
Adult
(63)
Middle Aged
(54)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasis

THU0149 Efficacy and Safety of Baricitinib in Japanese Rheumatoid Arthritis Patients at 12 Weeks

Wpływ typu gleby, pH, wilgotności i temperatury na fitotoksyczność i skuteczność zwalczania głowni cebuli (Urocystis magica Pass.) fungicydami z grup PCNB i TMTD

THU0175 Effects of Baricitinib on Multibiomarker Disease Activity Scores and Their Components in a Phase 2B Study in Moderate-to-Severe Rheumatoid Arthritis Patients

OP0047 Baricitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-Label, Long-Term Extension Study

OP0029 Baricitinib, An Oral Janus Kinase (JAK)1/JAK2 Inhibitor, in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to TNF Inhibitors: Results of the Phase 3 RA-Beacon Study

THU0226 Baricitinib Effects on Serum Cholesterol and Circulating Lipid Particles in a Phase 2B Study in Patients with Rheumatoid Arthritis

Cytochrome P-450 Polymorphisms and Response to Clopidogrel

Extracorporeal therapy requirements for patients with acute renal failure

A comparison of metabolic control by continuous and intermittent therapies in acute renal failure

Drotrecogin Alfa (Activated) in Adults with Septic Shock

Plasma protein adsorption to highly permeable hemodialysis membranes

Activated protein C levels in patients with severe sepsis: rebuttal

THU0149 Efficacy and Safety of Baricitinib in Japanese Rheumatoid Arthritis Patients at 12 Weeks: Table 1

Impact of the Nutritional Regimen on Protein Catabolism and Nitrogen Balance in Patients With Acute Renal Failure

Quantification of creatinine kinetic parameters in patients with acute renal failure

A blind clinical evaluation committee should, in theory, make data of a randomized clinical trial stronger, not weaker

Identification, Management, and Transition of Care for Patients With Opioid Use Disorder in the Emergency Department

Antithrombin and heparin may limit the activation of Protein C

Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death

The Return of the House Call: The Role of Internet-Based Interactivity in Bringing Health Information Home to Older Adults

Vancomycin pharmacokinetics in acute renal failure: Preservation of nonrenal clearance

A CONTENT ANALYSIS OF DIRECT-TO-CONSUMER (DTC) PRESCRIPTION DRUG WEB SITES

THU0175 Effects of Baricitinib on Multibiomarker Disease Activity Scores and Their Components in a Phase 2B Study in Moderate-to-Severe Rheumatoid Arthritis Patients: Table 1

Comparison of imipenem pharmacokinetics in patients with acute or chronic renal failure treated with continuous hemofiltration

Suchergebnisse filtern